Phase I trials in patients with relapsed, advanced upper gastrointestinal carcinomas: experience in a specialist unit
Conclusion
Phase I clinical trials can be considered a reasonable option in selected patients with relapsed UGIC. The use of objective prognosticators may improve selection and risk/benefit profile of patients.
Source: Gastric Cancer - Category: Gastroenterology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Clinical Trials | Gastric (Stomach) Cancer | Gastroenterology | Study | Toxicology